Sarah Renna is serving as the interim associate director of MURR’s Products and Services division.  In the role she oversees the production and compliance of three FDA GMP regulated radiopharmaceutical production processes for carrier-added Lu-177, no-carrier-added Lu-177 and I-131.

Prior to her current position, she was the radiopharmaceutical production manager, overseeing the production processes for Mo-99, Lu-177, and I-131. She also served as a radiopharmaceutical production team lead.

She received a B.A. in Psychology from the University of Missouri-Columbia after which she joined Sinclair Research Center (SRC), a contract research organization specializing in pre-clinical toxicology and DMPK work.  During her time there, she received a Master’s Degree in Pharmacology/Toxicology from Michigan State University.  During her seven years at SRC, she served in many roles but spent the majority of time as a Study Director managing pharmacokinetic studies in diabetic and non-diabetic miniature swine.